Analysis | Metabolite Name | Measured Value | Units | Cell Type | Stimulation |
---|---|---|---|---|---|
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 92675 | Peak area | HAHA | Untreated |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 148227 | Peak area | HAHA | TNF-alpha |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 166288 | Peak area | BS4 | Untreated |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 201520 | Peak area | BS4 | TNF-alpha+IL-17A |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 208931 | Peak area | BS4 | IFN-G |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 255473 | Peak area | PAK | TNF-alpha |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 261457 | Peak area | BS4 | IL-17A |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 268250 | Peak area | PAK | IFN-G |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 276773 | Peak area | HAHA | IFN-G |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 313017 | Peak area | PAK | IL-17A |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | 319669 | Peak area | PAK | Untreated |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | Peak area | BS4 | TNF-alpha | |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | Peak area | HAHA | IL-17A | |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | Peak area | HAHA | TNF-alpha+IL-17A | |
Reversed phase POSITIVE ION MODE | CREATINE (CAS# 57-00-1); (M+H)+ | Peak area | PAK | TNF-alpha+IL-17A |